SAGE's (SAGE) zuranalone Risk/Benefit Not Very Favorable, Opportunity is Niche - Analyst

Go back to SAGE's (SAGE) zuranalone Risk/Benefit Not Very Favorable, Opportunity is Niche - Analyst
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 206.20 +1.98 (0.97%)
Previous Close $204.22    52 Week High $333.65 
Open $205.26    52 Week Low $223.02 
Day High $207.36    P/E 26.40 
Day Low $203.13    EPS $7.81 
Volume 1,013,334       

Sagebrush Gold Ltd. (NASDAQ: SAGE) Delayed: 32.24 +0.31 (0.97%)
Previous Close $31.93    52 Week High $62.64 
Open $31.85    52 Week Low $26.28 
Day High $32.54    P/E N/A 
Day Low $31.23    EPS $-0.94 
Volume 558,229